Clinical Trial Update: Polyethylene Glycol Loxenatide Pharmacokinetics Study in Subjects With Normal and Insufficiency Renal Function [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetics study investigates polyethylene glycol loxenatide in subjects with normal and impaired renal function for Type 2 Diabetes Mellitus…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Polyethylene Glycol Loxenatide (polyethylene glycol loxenatide)

Snippet

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: UNKNOWN